*If the study population selected is at high risk for the disease for which the drug/intervention is tested, the participants will be strongly motivated and more cooperative compared to those at usual or normal risk.

Significant difference between the outcomes of the two groups depends not only on sample size and elimination of biases but also on the compliance.